Immunis
Irvine, United States· Est. 2018
Immunis is a clinical-stage biotechnology company targeting age-driven diseases to promote a healthier lifespan.
Private Company
Total funding raised: $14.5M
About
Immunis is a clinical-stage biotechnology company targeting age-driven diseases to promote a healthier lifespan.
Biologics
Funding History
2Total raised:$14.5M
Series A$12MJun 15, 2022
Seed$2.5MJun 15, 2020